2335
INTRODUCTION
Human rhinoviruses (HRVs), primary causative agents of the 'common cold' (Tyrrell & Bynoe, 1966; Gwaltney, 1983) , have a narrow host range, replicating only in higher primates. A small animal model for HRV infection has been lacking and current in vivo tests of potential antivirals use primates (Shipkowitz et aL, 1972) which are expensive, or mice infected with indicator viruses (Eggers, 1976; Herrmann et al., 1982) which do not cause upper respiratory tract infections.
Because mouse cells have receptors for a few serotypes of rhinoviruses (Yin & Lomax, 1983) , we attempted to use the mouse as a non-primate host for rhinovirus infection. Our approach was to select host range variants of human rhinovirus type 2 (HRV2/H) in tissue culture and then test these variants for their ability to replicate in mice. Non-permissive host cells were used as the only selective pressure; no mutagens were used. We reported previously the successful selection of a variant which replicates in a mouse cell line (Yin & Lomax, 1983) . This paper describes the continuation of that work and the demonstration of replication of a rhinovirus variant in mice.
METHODS

Cells.
HeLa cells were obtained from Flow Laboratories. They were maintained as monolayers at 37 °C in McCoy's 5A medium (modified) (Gibco), containing 10~ heat-inactivated calf serum, gentamicin (50 ~tg/ml) and fungisone (2.5 ~tg/ml).
L cells, strain LM, were originally obtained from the American Type Culture Collection, and have been maintained in our laboratory since 1974. A subculture of these L cells which best supported replication of the rhinovirus host range variant was used throughout this study. L cells were propagated as monolayers in Eagle's MEM with Earle's salts (Gibco), supplemented with 7~ heat-inactivated foetal bovine serum, and antimicrobial agents as listed above. Cells were karyotyped to confirm the mouse origin of this cell line.
Mice. All inbred mice were from Jackson Laboratories, Bar Harbor, Me., U.S.A. CD-I mice were from Charles River Breeding Laboratories, Wilmington, Mass., U.S.A.
Organ culture of mouse nasal turbinates. Organ cultures were prepared by aseptically removing the turbinates from 6-week-old, CD-1 mice and placing the turbinate tissue in culture medium without serum for 3 days before use for virus infection.
Viruses. HRV2 strain HGP was obtained from R. Grunert (E. I. du Pont de Nemours & Co.). Host range variants of HRV2/H were obtained as summarized in Fig. 1 (Yin & Lomax, 1983) . L cells were used exclusively for all subsequent virus propagations. Photosensitive HRV2/L was prepared by growing the virus in L cells in MEM, supplemented with 1 ~ foetal bovine serum and neutral red (Hartman-Leddon Co., Philadelphia, Pa., U.S.A.) at 4 l.tg/ml. All operations involving the propagation and use of photosensitive virus were carried out under red light (650 to 700 nm). Photosensitive HRV2/L was harvested 24 h post-infection and concentrated from the L cell cytoplasm by centrifugation (1.6 x l0 T g-min). This virus was used to infect organ cultures of mouse turbinates. Twenty-four h after infection, the turbinates were homogenized in 1 ml culture medium. Photosensitive virus, residual from the inoculum, was inactivated by placing the homogenate samples in Petri dishes, with constant stirring, 8 cm from a light source (Type BL, General Electric, 14 W, 360 nm peak) for 30 min at 4 °C. The light-insensitive progeny virus (HRV2/T) was again propagated in L cells, made photosensitive and used to infect CD-1 mice. At 24 h postinfection, light insensitive progeny virus was recovered from the lung homogenate of infected animals. HRV2/M was obtained by plaque isolation following passage and replication of HRV2/T in an individual CD-1 mouse, The identities of all of the above variants were confirmed by neutralization tests with standard antisera against HRV2/H.
Infection of mice and assay for virus growth.
Each experimental group routinely consisted of six, 4-week-old female mice. All mice were pretreated intranasally with 50 gl Cosmegen® (soluble actinomycin D; Merck, Sharpe & Dohme) at 0.25 mg/kg body weight, at either -24 h or -4 h. At 0 h, all animals were infected intranasally with 50 gl photosensitive HRV2/M containing approximately 108 p.f.u. All mice were anaesthetized with ether prior to intranasal treatment. Two mice from each group were sacrificed by cervical dislocation at 2 h after virus infection to determine levels of residual input virus, while the remaining mice were sacrificed at 24 h. Lungs were excised from each animal and homogenized in 3 ml culture medium and the homogenates were cleared of debris by lowspeed centrifugation. Photosensitive virus was inactivated by exposing the homogenate to white light for 30 min; the virus titre of each sample was then determined by plaque assay on L cells. Virus replication for each mouse was calculated as follows. Replication index = virus titre at 24 h for individual/mean virus titre at 2 h for experimental group. Infection procedure was as described in Methods. All mice were pretreated with Cosmegen ® at -24 h, with the exception of the BALB/cOuJ-nude mouse strain which was tested without Cosmegen ®. Each point on the figure represents mean replication for each group + S.E.M.
RESULTS
A rhinovirus variant with altered host range was selected in a stepwise manner using a nonpermissive host as the only selective pressure (Fig. 1) . This variant was subsequently used to infect organ cultures derived from mouse nasal turbinates. Initially, we could not detect virus replication in the organ culture in the presence of a high background of input virus. This difficulty was circumvented by using a photosensitive inoculum (Wilson & Cooper, 1963) . HRV2/L, containing neutral red, was found to be fully infectious when maintained in the dark, but 99.99 ~ could be inactivated by white light. [In contrast to one published report (Madshus et al., 1984) , we found no loss of infectivity in HRV2 preparations containing neutral red if maintained in the dark.] Thus, low levels of light-resistant progeny virus from HRV2/L-infected turbinate organ culture could be readily distinguished from non-eclipsed light-sensitive input virus. This same procedure employing photosensitive virus was used to obtain HRV2 able to replicate in the mouse (HRV2/m). Finally, HRV2/M was plaque-purified and propagated in L cells prior to use in animal experiments.
For growth and detection of virus in vivo, we used photosensitive HRV2/M as inoculum, in mice treated intranasally with Cosmegen® at 0.25 mg/kg body weight 24 h before infection. HRV2/M was found to replicate about 10-fold in CD-1 mice; however, we found that genetically inbred mice supported more reproducible and vigorous virus growth. Inbred mouse strains BALB/cJ, CBA/J, DBA/2J, A/J, SJL/J and BALB/cOuJ-nude were tested. The results are presented in Fig. 2 . Although BALB/cOuJ-nude mice supported virus replication without Cosmegen® pretreatment, BALB/cJ mice, with Cosmegen® pretreatment, provided the best virus yield and reproducibility and were therefore chosen as the preferred strain for routine studies.
Higher virus replication and reduced variability were repeatedly found in Cosmegen®-treated animals. The correlation between Cosmegen® pretreatment and virus replication is shown in Table 1 . In later experiments, we observed several-fold additional enhancement of virus replication when Cosmegen® was administered intranasally at only 4 h prior to virus infection, as demonstrated by the results in Table 2 .
To determine the kinetics of virus replication, BALB/cJ mice were pretreated intranasally with Cosmegen®, followed by intranasal virus administration after 4 h. As shown in Fig. 3 , virus titre in the mouse lungs reached a maximum at 24 h after intranasal infection, and then declined Fig. 3 . Kinetics of HRV2/M replication in BALB/cJ mice. Infection procedure was as described in Methods, except all mice were pretreated with Cosmegen ® at -4 h. Groups of five mice were sacrificed at various times after virus administration and lung homogenates were assayed for light-insensitive virus. 0, Titre from individual animals; 7q, geometric mean titre for groups of animals at specified times. * Lung tissue and turbinate tissue of the infected mice were aseptically removed and homogenized in 3 ml and 1 ml culture medium, respectively, and virus titre determined. 1" Virus titres are presented as the geometric mean for each group.
slowly over the next 48 h. The variability of virus titres among animals increased greatly after 24 h. The titre reached a minimum at 8 h post-infection, but since this model was to be used for testing antivirals (usually administered at less than 8 h), the titre at 2 h was used to calculate the viral replication index.
It was important to demonstrate that the virus that replicated in the mouse was the selected host range variant. This was done by infecting groups of BALB/cJ mice with either the selected variant HRV2/M or the parental virus HRV2/H. As indicated in Table 2 , virus titres of lung homogenates from mice infected with HRV2/M increased > 300-fold during the 24 h period whereas titres from mice infected with HRV2/H decreased about 10-fold in the same time period. These results clearly demonstrate that only the selected host range variant is capable of significant replication in the mouse lung. Importantly, the replication of the variant also occurs in mouse nasal turbinates (Table 2) , resembling viral replication during HRV infection.
We reported previously that the restriction of HRV2/H replication in mouse L cells occurs during early viral replicative events subsequent to viral adsorption and penetration and that the only measurable alteration of the host range variant HRV2/L is in a non-structural protein, P2-5b (Yin & Lomax, 1983) . Differences between virions of HRV2/H and HRV2/L or HRV2/M appear to be minor; we could detect no changes in antigenicity or acid lability. HRV2/M has an increase in the apparent molecular weight of a non-structural protein (P2-5b), identical to the alteration observed in HRV2/L; the function of the protein is as yet unknown. More detailed comparisons of the RNAs are in progress.
DISCUSSION
We have sclcctcd a host range variant of HRV2/H, which diffcrs only marginally from HRV2/H by various biochcmical paramctcrs, and which can replicate 50-to 300-fold in the mouse lung. The proccdurc for selecting host range variants is gcncrally applicable to other rhinoviruscs for which L cells havc receptors. For example, variants of HRVIA have bccn sclcctcd and shown to replicate more than 100-fold in the mousc lung (same procedure; F. H. Yin & N. B. Lomax, unpublishcd results) . Such a mousc model of HRV infcction should bc useful for testing thc efficacy of antiviral compounds or potcntial vaccines.
Although the mcchanism for its effect is not well undcrstood, actinomycin D prctrcatment is an important facet of our model. For thc tcsting of some antivirals, this pretrcatment could have a confounding cffcct. The dosagc used has no apparent long-term toxic effects on the animals. Cosmcgen® may act to supprcss host dcfcnces, sincc prctrcatmcnt of thc mice with indomcthacin, a known immunosupprcssivc agent, yiclds parallel virus replication rcsults (F. H. Yin & N. B. Lomax, unpublished data) .
Other variablcs in our cxpcrimcnts should also bc mcntioncd. Thc host range variant, HRV2/L, has bccn shown in tissue culture to bc somewhat less sensitive than thc parent strain to thc antiviral effects of compounds which inhibit viral RNA synthesis (Yin & Lomax, 1983) . The diffcrcnces arc not grcat, howcvcr; the 90~o tissue culture effective doses for the two viruscs have ncvcr bccn greatcr than twofold for any inhibitor tested. In addition, there is somc variability of virus rcplication between cxperiments using diffcrcnt inocula (e.g. 355-fold replication in Tablc 2 and 36-fold replication in Fig. 3 ). This probably reflccts the levels of residual photoinscnsitivc virus bctwccn inocula, which would amplify the variability of thc resultant virus replication index. In our hands, cxpcrimcnts performed using identical inocula routinely yielded excellent reproducibility.
This mouse model is the first reported example of HRV replication in small laboratory animals. Moreover, the model provides an acccurate and reproducible in vivo assay of HRV2 replication which is much more convenient than the currently available alternatives (Shipkowitz et al., 1972; Eggers, 1976; Herrmann et al., 1982) .
